154 related articles for article (PubMed ID: 17966956)
1. Marked elevation of liver transaminases after high-dose fluvastatin unmasks chronic hepatitis C: safety and re-challenge.
Chen YW; Lai HW; Wang TD
Acta Neurol Taiwan; 2007 Sep; 16(3):163-7. PubMed ID: 17966956
[TBL] [Abstract][Full Text] [Related]
2. Fluvastatin inhibits hepatitis C replication in humans.
Bader T; Fazili J; Madhoun M; Aston C; Hughes D; Rizvi S; Seres K; Hasan M
Am J Gastroenterol; 2008 Jun; 103(6):1383-9. PubMed ID: 18410471
[TBL] [Abstract][Full Text] [Related]
3. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
4. Lovastatin and fluvastatin reduce viremia and the pro-inflammatory cytokines in the patients with chronic hepatitis C.
Mihăilă R; Nedelcu L; Frăţilă O; Rezi EC; Domnariu C; Ciucă R; Zaharie AV; Olteanu A; Bera L; Deac M; Mihăilă R
Hepatogastroenterology; 2009; 56(96):1704-9. PubMed ID: 20214221
[TBL] [Abstract][Full Text] [Related]
5. Risk reduction and tolerability of fluvastatin in patients with the metabolic syndrome: a pooled analysis of thirty clinical trials.
Winkler K; Ablethauser CB; Gimpelewicz C; Bortolini M; Isaacsohn JL
Clin Ther; 2007 Sep; 29(9):1987-2000. PubMed ID: 18035198
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune hepatitis after treatment with fluvastatin.
Castiella A; Fernandez J; Zapata E
Liver Int; 2007 May; 27(4):592. PubMed ID: 17403199
[No Abstract] [Full Text] [Related]
7. Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.
Conforti A; Magro L; Moretti U; Scotto S; Motola D; Salvo F; Ros B; Leone R
Drug Saf; 2006; 29(12):1163-72. PubMed ID: 17147462
[TBL] [Abstract][Full Text] [Related]
8. Fluvastatin treatment is not associated with an increased incidence of cancer.
Stein EA; Corsini A; Gimpelewicz CR; Bortolini M; Gil M
Int J Clin Pract; 2006 Sep; 60(9):1028-34. PubMed ID: 16939542
[TBL] [Abstract][Full Text] [Related]
9. Statin safety: lessons from new drug applications for marketed statins.
Jacobson TA
Am J Cardiol; 2006 Apr; 97(8A):44C-51C. PubMed ID: 16581328
[TBL] [Abstract][Full Text] [Related]
10. Safety profile of fluvastatin.
Peters TK
Br J Clin Pract Suppl; 1994 Dec; (77):20-3. PubMed ID: 19489170
[TBL] [Abstract][Full Text] [Related]
11. Safety profile of fluvastatin.
Peters TK
Br J Clin Pract Suppl; 1996 Jan; 77A():20-3. PubMed ID: 8729586
[TBL] [Abstract][Full Text] [Related]
12. Chronic cough as a complication of treatment with statins: a case report.
Psaila M; Fsadni P; Montefort S
Ther Adv Respir Dis; 2012 Aug; 6(4):243-6. PubMed ID: 22761129
[TBL] [Abstract][Full Text] [Related]
13. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
[TBL] [Abstract][Full Text] [Related]
14. Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers.
Yasue H; Mizuno Y; Harada E; Itoh T; Nakagawa H; Nakayama M; Ogawa H; Tayama S; Honda T; Hokimoto S; Ohshima S; Hokamura Y; Kugiyama K; Horie M; Yoshimura M; Harada M; Uemura S; Saito Y;
J Am Coll Cardiol; 2008 May; 51(18):1742-8. PubMed ID: 18452779
[TBL] [Abstract][Full Text] [Related]
15. Incidence of statin hepatotoxicity in patients with hepatitis C.
Khorashadi S; Hasson NK; Cheung RC
Clin Gastroenterol Hepatol; 2006 Jul; 4(7):902-7; quiz 806. PubMed ID: 16697272
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced liver injury associated with statins.
Russo MW; Scobey M; Bonkovsky HL
Semin Liver Dis; 2009 Nov; 29(4):412-22. PubMed ID: 19826975
[TBL] [Abstract][Full Text] [Related]
17. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
Skalicka B; Kubanek M; Malek I; Vymetalova Y; Hoskova L; Podzimkova M; Kautzner J
J Heart Lung Transplant; 2009 Jun; 28(6):598-604. PubMed ID: 19481021
[TBL] [Abstract][Full Text] [Related]
18. Short-term effects of fluvastatin therapy on plasma interleukin-10 levels in patients with chronic heart failure.
Tekin A; Sezgin N; Katircibaşi MT; Tekin G; Cölkesen Y; Sezgin AT; Müderrisoğlu H
Coron Artery Dis; 2008 Nov; 19(7):513-9. PubMed ID: 18923248
[TBL] [Abstract][Full Text] [Related]
19. [High therapeutic effect and safety of fluvastatin].
Pharm Unserer Zeit; 2003; 32(6):516-7. PubMed ID: 14639833
[No Abstract] [Full Text] [Related]
20. Deteriorating effect of fluvastatin on the cholestatic liver injury induced by bile duct ligation in rats.
Lotková H; Staňková P; Roušar T; Kučera O; Kohoutek L; Mičuda S; Brčáková E; Kolouchová G; Cervinková Z
Gen Physiol Biophys; 2011 Mar; 30(1):66-74. PubMed ID: 21460414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
